Skip to content Skip to footer

Budget 2026-27 Prioritizes MSMEs, Biopharma and Semiconductor Manufacturing  

Budget 2026-27 Prioritizes MSMEs, Biopharma and Semiconductor Manufacturing

The Union Budget 2026-27 places strong emphasis on strengthening India’s industrial and manufacturing base, with a focus on both traditional industries and high-growth sectors.  
 
Presenting the Budget, Finance Minister Nirmala Sitharaman outlined a series of measures aimed at empowering micro, small and medium enterprises (MSMEs) through improved access to capital, simplified compliance norms and professional support to create a “champion ecosystem” for sustainable growth. To boost innovation in healthcare, the government proposed a ₹10,000 crore BioPharma Fund to position India as a global hub for biologics, targeting emerging health challenges such as diabetes, cancer and autoimmune diseases. 

With a ₹40,000 crore provision for semiconductor and electronics production under an expanded ISM 2.0 initiative, the Budget also expedites India’s transition to technical self-reliance. In addition, specialized corridors and cluster-based chemical parks are planned to improve the chemicals and rare-earth industries and reduce import dependence. 

Proposals like a Mega Textile Park, National Fiber Scheme, and increased skilling initiatives will help the textile industry, while the localization of high-end machinery will promote the manufacturing of infrastructure and construction equipment. Additionally, 200 legacy industry clusters will be upgraded as part of the budget to boost employment, productivity, and innovation. 

Leave a comment